News

US health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices.
While neither warning is classified as a recall, the FDA has provided additional information for the two products. Boston ...
Boston Scientific’s AI leadership, global growth, and strong R&D make it a long-term winner despite valuation and regulatory ...
The National Consumer Commission has urgently recalled specific Boston Scientific Encore medical devices after contamination ...
Boston Scientific BSX has put up double-digit sales and profit growth figures every quarter for at least the last two years.
The update covers devices used in procedures to implant the company’s Watchman heart device.
The FDA is reviewing Boston Scientific's defibrillator leads after reports of rising shock impedance and 16 related deaths.
A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...
Boston Scientific improved B2B search experiences by integrating AI-enabled search from Coveo into their SAP Commerce Cloud stack.
The FDA has issued an alert regarding a safety concern with certain Boston Scientific defibrillator leads used in implantable cardioverter defibrillators. The affected models include Endotak Reliance, ...
Boston Scientific Corporation (NYSE:BSX) is one of the most profitable growth stocks to buy according to billionaires.
Marlborough, Mass.-based Boston Scientific’s new Endura Weight Loss Solutions offers minimally invasive procedures for patients who want alternatives to diet, medication and bariatric surgery.